COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,646 Articles (22,913 medRxiv, 8,733 bioRxiv)

Most recent first Previous |  Page 1682: Articles 16811-16820  | Next

Uneven growth of SARS-CoV-2 clones evidenced by more than 500,000 whole-genome sequences
Zeng, H.-L., Liu, Y., Thorell, K., Norden, R., Aurell, E.
10.1101/2021.04.06.437914 — Posted: 2021-04-06
Altered O-glycosylation Level of SARS-CoV-2 Spike Protein by Host O-glycosyltransferase Strengthens Its Trimeric Structure
Xu, Z., Ku, X., Tian, J., Zhang, H., Hou, J., Zhang, C., Shi, J., Li, Y., Kaji, H., Tao, S.-c., Kuno, A., Yan, W., Da, L.-T., Zhang, Y.
10.1101/2021.04.06.438614 — Posted: 2021-04-06
Ageing impairs the airway epithelium defence response to SARS-CoV-2
Capraro, A., Wong, S. L., Adhikari, A., Allan, K. M., Patel, H. R., Zhong, L., Raftery, M., Jaffe, A., Yeang, M., Aggarwal, A., Wu, L., Pandzic, E., Whan, R. M., Turville, S., Vittorio, O., Bull, R. A., Kaakoush, N., Rawlinson, W. D., Tedla, N., Vafaee, F., Waters, S. A.
10.1101/2021.04.05.437453 — Posted: 2021-04-06
ADNKA overcomes SARS-CoV2-mediated NK cell inhibition through non-spike antibodies
Fielding, C. A., Sabberwal, P., Williamson, J. C., Greenwood, E. J., Crozier, E., Zelek, W., Seow, J., Graham, C., Huettner, I., Edgeworth, J., Morgan, B. P., Ladell, K., Eberl, M., Humphreys, I. R., Merrick, B., Doores, K. J., Wilson, S. J., Lehner, P. J., Wang, E., Stanton, R. J.
10.1101/2021.04.06.438630 — Posted: 2021-04-06
High-Potency Polypeptide-based Interference for Coronavirus Spike Glycoproteins
Ma, J., Campos Acevedo, A., Wang, Q.
10.1101/2021.04.05.438537 — Posted: 2021-04-06
Plasma microbiome in COVID-19 subjects: an indicator of gut barrier defects and dysbiosis
Prasad, R., Patton, M. J., Floyd, J. L., Vieira, C. P., Fortmann, S. D., DuPont, M., Harbour, A., Chen See, J. R., Wright, J., Lamendella, R., Stevens, B. R., Grant, M. B.
10.1101/2021.04.06.438634 — Posted: 2021-04-06
Murine monoclonal antibodies against RBD of SARS-CoV-2 neutralize authentic wild type SARS-CoV-2 as well as B.1.1.7 and B.1.351 viruses and protect in vivo in a mouse model in a neutralization dependent manner
Amanat, F., Strohmeier, S., Lee, W.-H., Bangaru, S., Ward, A. B., Coughlan, L., Krammer, F.
10.1101/2021.04.05.438547 — Posted: 2021-04-06
Unique protein features of SARS-CoV-2 relative to other Sarbecoviruses
Cotten, M., Robertson, D. L., Phan, M. V. T.
10.1101/2021.04.06.438675 — Posted: 2021-04-06
Effects of worldwide interventions and vaccination on COVID-19 between waves and countries
Ge, Y., Zhang, W., Liu, H., Ruktanonchai, C. W., Hu, M., Wu, X., Song, Y., Ruktanonchai, N. W., Yan, W., Feng, L., Li, Z., Yang, W., Liu, M., Tatem, A. J., Lai, S.
10.1101/2021.03.31.21254702 — Posted: 2021-04-06
Covid-19 and excess mortality rates not comparable across countries
Kelly, G. E., Petti, S., Noah, N.
10.1101/2021.03.31.21254689 — Posted: 2021-04-06

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).